1-[[3-[(2-methylpropylamino)methyl]oxolan-3-yl]methyl]piperidin-3-ol

C15H30N2O2 — CID 62261044

IUPAC1-[[3-[(2-methylpropylamino)methyl]oxolan-3-yl]methyl]piperidin-3-ol
SMILESCC(C)CNCC1(CN2CCCC(O)C2)CCOC1
InChIInChI=1S/C15H30N2O2/c1-13(2)8-16-10-15(5-7-19-12-15)11-17-6-3-4-14(18)9-17/h13-14,16,18H,3-12H2,1-2H3
InChIKeyGRXMODOPDQZKMP-UHFFFAOYSA-N
MW270.42 g/mol
LogP1.10
Rot. Bonds6

About 1-[[3-[(2-methylpropylamino)methyl]oxolan-3-yl]methyl]piperidin-3-ol

1-[[3-[(2-methylpropylamino)methyl]oxolan-3-yl]methyl]piperidin-3-ol (PubChem CID 62261044) has the molecular formula C15H30N2O2 and a molecular weight of 270.42 g/mol. Its IUPAC name is 1-[[3-[(2-methylpropylamino)methyl]oxolan-3-yl]methyl]piperidin-3-ol.

Molecular Properties

Compound Name1-[[3-[(2-methylpropylamino)methyl]oxolan-3-yl]methyl]piperidin-3-ol
PubChem CID62261044
Molecular FormulaC15H30N2O2
Molecular Weight270.42 g/mol
Exact Mass270.23
IUPAC Name1-[[3-[(2-methylpropylamino)methyl]oxolan-3-yl]methyl]piperidin-3-ol
SMILESCC(C)CNCC1(CN2CCCC(O)C2)CCOC1
InChIInChI=1S/C15H30N2O2/c1-13(2)8-16-10-15(5-7-19-12-15)11-17-6-3-4-14(18)9-17/h13-14,16,18H,3-12H2,1-2H3
InChIKeyGRXMODOPDQZKMP-UHFFFAOYSA-N
XLogP1.10
TPSA44.73 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds6
Heavy Atoms19
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500270.42
LogP ≤ 51.10
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Analyze 1-[[3-[(2-methylpropylamino)methyl]oxolan-3-yl]methyl]piperidin-3-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-methyl-N-[[3-[(4-methyl-1,4-diazepan-1-yl)methyl]oxolan-3-yl]methyl]propan-1-amine
CID 62261940
[4-[[3-[(2-methylpropylamino)methyl]oxolan-3-yl]methyl]morpholin-2-yl]methanol
CID 81214333
2-methyl-N-[[3-[(2-methyl-1,4-oxazepan-4-yl)methyl]oxan-3-yl]methyl]propan-1-amine
CID 63741753
1-[[4-[(2-methylpropylamino)methyl]oxan-4-yl]methyl]pyrrolidine-3,4-diol
CID 106674199
3-methyl-1-[[3-[(2-methylpropylamino)methyl]oxolan-3-yl]methyl]pyrrolidin-3-ol
CID 103358497
2-methyl-N-[[3-(morpholin-4-ylmethyl)oxan-3-yl]methyl]propan-1-amine
CID 55243009
N-[[3-[(7,7-dimethyl-1,4-thiazepan-4-yl)methyl]oxolan-3-yl]methyl]-2-methylpropan-1-amine
CID 107459363
2-methyl-N-[[3-[(2-methylpyrrolidin-1-yl)methyl]oxan-3-yl]methyl]propan-1-amine
CID 63740980
N-[[3-[(2-ethylazepan-1-yl)methyl]oxolan-3-yl]methyl]-2-methylpropan-1-amine
CID 104691962
[1-[[1-[(2-methylpropylamino)methyl]cyclohexyl]methyl]piperidin-3-yl]methanol
CID 62276462
N-[[3-[(4-methylazepan-1-yl)methyl]oxolan-3-yl]methyl]propan-2-amine
CID 55249798
2-[1-[[3-(methylaminomethyl)oxolan-3-yl]methyl]piperidin-3-yl]ethanol
CID 107228855

Frequently Asked Questions

What is the IUPAC name of 1-[[3-[(2-methylpropylamino)methyl]oxolan-3-yl]methyl]piperidin-3-ol?
The IUPAC name of 1-[[3-[(2-methylpropylamino)methyl]oxolan-3-yl]methyl]piperidin-3-ol (CID 62261044) is 1-[[3-[(2-methylpropylamino)methyl]oxolan-3-yl]methyl]piperidin-3-ol.
What is the SMILES notation for 1-[[3-[(2-methylpropylamino)methyl]oxolan-3-yl]methyl]piperidin-3-ol?
The canonical SMILES for 1-[[3-[(2-methylpropylamino)methyl]oxolan-3-yl]methyl]piperidin-3-ol is CC(C)CNCC1(CN2CCCC(O)C2)CCOC1.
What is the InChIKey of 1-[[3-[(2-methylpropylamino)methyl]oxolan-3-yl]methyl]piperidin-3-ol?
The InChIKey is GRXMODOPDQZKMP-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H30N2O2/c1-13(2)8-16-10-15(5-7-19-12-15)11-17-6-3-4-14(18)9-17/h13-14,16,18H,3-12H2,1-2H3.
What are the key properties of 1-[[3-[(2-methylpropylamino)methyl]oxolan-3-yl]methyl]piperidin-3-ol?
1-[[3-[(2-methylpropylamino)methyl]oxolan-3-yl]methyl]piperidin-3-ol has a molecular weight of 270.42 g/mol, XLogP of 1.10, 6 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[[3-[(2-methylpropylamino)methyl]oxolan-3-yl]methyl]piperidin-3-ol is sourced from PubChem (CID 62261044), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).